DAA2135 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
193.5% Increase Gene Expression Level |
|
DAA2149 |
complement component 4A increases with age |
Molecular |
hippocampus |
Human |
C4A |
216.4% Increase Gene Expression Level |
|
DAA1423 |
peptidoglycan recognition protein 1 |
Molecular |
hippocampus |
Mouse |
Pglyrp1 |
8.0% Increase Gene Expression Level |
|
DAA2360 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
204.2% Increase Gene Expression Level |
|
DAA1420 |
programmed cell death 4 |
Molecular |
hippocampus |
Mouse |
Pdcd4 |
2.0% Increase Gene Expression Level |
|
DAA2148 |
complement component 4A increases with age |
Molecular |
hippocampus |
Human |
C4A |
226.3% Increase Gene Expression Level |
|
DAA2361 |
major histocompatibility complex, class II, DR beta 4 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB4 |
177.7% Increase Gene Expression Level |
|
DAA1393 |
progressive ankylosis |
Molecular |
hippocampus |
Mouse |
Ank |
1.0% Increase Gene Expression Level |
|
DAA1424 |
protein tyrosine phosphatase, receptor type, O |
Molecular |
hippocampus |
Mouse |
Ptpro |
5.0% Decrease Gene Expression Level |
|